EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence

Mohamed S. Sedeek, Nesma M. Ahmed, Salma M. Ahmed, Asmaa A. Bakr, Donia Khaled, Hebattallah W. Farouk

Science and Technology Nexus · 11.07.2026 · 1-7

DOI: 10.25259/stn_16_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science and Technology Nexus, online erschienen am 11.07.2026. Verfasst von Mohamed S. Sedeek und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhiza glabra L. (licorice), renowned in ethnopharmacology, harbors bioactive metabolites such as glycyrrhizin, liquiritin, and flavonoids that confer antiviral, anti-inflammatory, antioxidant, and immunomodulatory properties pertinent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This review appraises in vitro, in silico , preclinical, and clinical data, revealing glycyrrhizin’s potent inhibition of SARS-CoV-2 main protease (Mpro; EC50 ≈ 0.44 mg/mL in Vero E6 cells) and disruption of envelope protein lipid interactions, alongside suppression of cytopathic effects and plaque formation. Anti-inflammatory efficacy stems from downregulated nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and cytokines (tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6)), mitigating cytokine storms, while immunostimulant effects include T-/B-lymphocyte proliferation and natural killer cell activation. Preliminary randomised trials (n=20-70) in mild-moderate coronavirus disease 2019 (COVID-19) demonstrate symptom alleviation (cough, dyspnea; p

Zitieren

APA

Sedeek, M. S., Ahmed, N. M., Ahmed, S. M., Bakr, A. A., Khaled, D., & Farouk, H. W. (2026). Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence. Science and Technology Nexus, 0, 1-7. https://doi.org/10.25259/stn_16_2026

Vancouver

Sedeek MS, Ahmed NM, Ahmed SM, Bakr AA, Khaled D, Farouk HW. Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence. Science and Technology Nexus. 2026;0:1-7. doi:10.25259/stn_16_2026

BibTeX
@article{Sedeek2026,
  author = {Sedeek, Mohamed S. and Ahmed, Nesma M. and Ahmed, Salma M. and Bakr, Asmaa A. and Khaled, Donia and Farouk, Hebattallah W.},
  title = {Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence},
  journal = {Science and Technology Nexus},
  year = {2026},
  volume = {0},
  pages = {1--7},
  doi = {10.25259/stn_16_2026}
}
Kostenlos starten →